This Week’s Biopharma News: New Approvals, Appeals, and AI
June 2, 2026
Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic
6 min read
False
June 2, 2026
Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic
6 min read
May 14, 2026
Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development
9 min read
May 12, 2026
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
6 min read
April 16, 2026
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
March 24, 2026
Modular automation with human oversight across laboratory and manufacturing scales
2 min read
March 23, 2026
An integrated machine learning framework adapts culture conditions during long perfusion runs
2 min read
March 19, 2026
Study models sustainable pricing for repurposed bevacizumab
2 min read
March 10, 2026
Automated text extraction connects culture conditions, purification steps, and productivity metrics
2 min read
By Yiting Lim
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
False
False
False
Affiliations:
Specialties:
Areas of Expertise: